APA (7th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. (2019). CADTH Canadian Drug Expert Committee recommendation: Indication : diabetes mellitus, type 2. Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.). CADTH.

Chicago Style (17th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Recommendation: Indication : Diabetes Mellitus, Type 2. Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.). Ottawa (ON): CADTH, 2019.

MLA (9th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Recommendation: Indication : Diabetes Mellitus, Type 2. Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.). CADTH, 2019.

Warning: These citations may not always be 100% accurate.